PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-62.12%
Negative revenue growth while ANO.AX stands at 62.13%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-4.76%
Negative gross profit growth while ANO.AX is at 251.94%. Joel Greenblatt would examine cost competitiveness or demand decline.
-133.92%
Negative EBIT growth while ANO.AX is at 155.25%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-133.92%
Negative operating income growth while ANO.AX is at 648.74%. Joel Greenblatt would press for urgent turnaround measures.
-104.47%
Negative net income growth while ANO.AX stands at 161.71%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-100.00%
Negative EPS growth while ANO.AX is at 161.29%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-100.00%
Negative diluted EPS growth while ANO.AX is at 161.54%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-3.68%
Share reduction while ANO.AX is at 0.62%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-7.83%
Reduced diluted shares while ANO.AX is at 0.46%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Dividend reduction while ANO.AX stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
49.89%
Positive OCF growth while ANO.AX is negative. John Neff would see this as a clear operational advantage vs. the competitor.
180.79%
Positive FCF growth while ANO.AX is negative. John Neff would see a strong competitive edge in net cash generation.
-12.63%
Negative 10Y revenue/share CAGR while ANO.AX stands at 223.10%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
66.44%
Positive 5Y CAGR while ANO.AX is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
68.94%
3Y revenue/share CAGR above 1.5x ANO.AX's 6.96%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
992.35%
10Y OCF/share CAGR above 1.5x ANO.AX's 77.99%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
163.21%
Positive OCF/share growth while ANO.AX is negative. John Neff might see a comparative advantage in operational cash viability.
1886.98%
3Y OCF/share CAGR above 1.5x ANO.AX's 878.66%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
-158.18%
Negative 10Y net income/share CAGR while ANO.AX is at 4293.06%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-105.95%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
69.70%
Positive short-term CAGR while ANO.AX is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
164.53%
5Y equity/share CAGR above 1.5x ANO.AX's 53.02%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
90.05%
3Y equity/share CAGR above 1.5x ANO.AX's 0.05%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-63.41%
Firm’s AR is declining while ANO.AX shows 53.52%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-10.39%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
9.77%
Asset growth above 1.5x ANO.AX's 3.20%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
2.75%
1.25-1.5x ANO.AX's 2.14%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-13.80%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-5.29%
We cut SG&A while ANO.AX invests at 14.86%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.